9N9-14282-53924
3 vaccinations
7 coded responses
40 check-ins
7 free-text entries
3 call cases
- Sex
- Male
- Age at first dose
- 46-50
- ZIP prefix
- 484 / MI
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-20
Dose 1 — Moderna
-
2021-01-21
Registered in v-safe
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
-
2021-02-18
Dose 2 — Moderna
-
2021-02-19
Survey response — days 1–6 daily, dose 2MedDRA: Back pain — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Mid-back painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-20
Survey response — days 1–6 daily, dose 2MedDRA: Back pain — Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Middle back painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-03-04
-
2021-03-11
Survey response — day 21, dose 2MedDRA: Erythema, Feeling hot — Feeling: GoodFree text: Bright red hot face and ears a couple times a day that takes 3 hours to go away.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-05-20
- 2021-08-19
-
2021-10-26
Dose 3 — Moderna
- 2021-10-26
-
2021-10-27
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Good · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-02
-
2021-11-09
Survey response — day 14, dose 3MedDRA: Cough, Headache, Pain, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Headache, cough, runny nose, body achesMedDRA releases: 2024-11 · check-in free text available
-
2021-11-18
Survey response — day 21, dose 3MedDRA: Chest pain, Dyspnoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Chest pain and shortness of breathMedDRA releases: 2024-11 · check-in free text available
-
2021-11-18
Report sent to call center — day 21, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-19
-
2021-11-23
Survey response — day 28, dose 3MedDRA: Cough, Oxygen saturation decreased, Total lung capacity decreased — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Persistent dry cough, nonstop, low oxygen levels and low lung capacity.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-23
Report sent to call center — day 28, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-11-29
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-11-30
- 2021-12-07
-
2022-01-25
Survey response — 3 months, dose 3MedDRA: Asthenia, Cognitive disorder, Delirium, Erythema, Impaired work ability, Inflammation, Lung disorder, Oxygen saturation decreased, Pre-existing disease, SARS-CoV-2 test negative, Visual impairment — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Loss of cognition to the point of delirium. Low O2 levels, vision problems, low energy, lung issues, red inflamed toes. Never a had positive Covid test but pretty sure had Covid in late October. Still unable to work.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-25
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-01-26
Call successfulParticipant prefers to complete VAERS report online
- 2022-04-28
- 2022-10-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-20 | Moderna | |
| 2 | 2021-02-18 | Moderna | |
| 3 | 2021-10-26 | Moderna | No |
Call center
3 call center cases
3 successful
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Mid-back pain
Systemic reaction (other): Middle back pain
Release 5 — day 21, dose 2
Symptoms: Bright red hot face and ears a couple times a day that takes 3 hours to go away.
Release 10 — day 14, dose 3
Symptoms: Headache, cough, runny nose, body aches
Release 10 — day 21, dose 3
Symptoms: Chest pain and shortness of breath
Release 10 — day 28, dose 3
Symptoms: Persistent dry cough, nonstop, low oxygen levels and low lung capacity.
Release 11 — 3 months, dose 3
Symptoms: Loss of cognition to the point of delirium. Low O2 levels, vision problems, low energy, lung issues, red inflamed toes. Never a had positive Covid test but pretty sure had Covid in late October. Still unable to work.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Cognitive disorder | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Delirium | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Erythema | ✓ | ✓ | ✓ |
| SD | Feeling hot | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Impaired work ability | · | · | ✓ |
| SD | Inflammation | · | · | ✓ |
| SD | Lung disorder | · | · | ✓ |
| SD | Oxygen saturation decreased | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Total lung capacity decreased | · | · | ✓ |
| SD | Visual impairment | · | · | ✓ |
| SRO | Back pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release